BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 28011586)

  • 1. Activation of PPAR-α in the early stage of heart failure maintained myocardial function and energetics in pressure-overload heart failure.
    Kaimoto S; Hoshino A; Ariyoshi M; Okawa Y; Tateishi S; Ono K; Uchihashi M; Fukai K; Iwai-Kanai E; Matoba S
    Am J Physiol Heart Circ Physiol; 2017 Feb; 312(2):H305-H313. PubMed ID: 28011586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ablation of cardiac TIGAR preserves myocardial energetics and cardiac function in the pressure overload heart failure model.
    Okawa Y; Hoshino A; Ariyoshi M; Kaimoto S; Tateishi S; Ono K; Uchihashi M; Iwai-Kanai E; Matoba S
    Am J Physiol Heart Circ Physiol; 2019 Jun; 316(6):H1366-H1377. PubMed ID: 30901275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PGC-1β deficiency accelerates the transition to heart failure in pressure overload hypertrophy.
    Riehle C; Wende AR; Zaha VG; Pires KM; Wayment B; Olsen C; Bugger H; Buchanan J; Wang X; Moreira AB; Doenst T; Medina-Gomez G; Litwin SE; Lelliott CJ; Vidal-Puig A; Abel ED
    Circ Res; 2011 Sep; 109(7):783-93. PubMed ID: 21799152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of heart failure by minimally invasive aortic constriction in mice: reduced peroxisome proliferator-activated receptor γ coactivator levels and mitochondrial dysfunction.
    Faerber G; Barreto-Perreia F; Schoepe M; Gilsbach R; Schrepper A; Schwarzer M; Mohr FW; Hein L; Doenst T
    J Thorac Cardiovasc Surg; 2011 Feb; 141(2):492-500, 500.e1. PubMed ID: 20447656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing fatty acid oxidation elicits a sex-dependent response in failing mouse hearts.
    Ritterhoff J; McMillen TS; Villet O; Young S; Kolwicz SC; Senn T; Caudal A; Tian R
    J Mol Cell Cardiol; 2021 Sep; 158():1-10. PubMed ID: 33989657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preservation of Acyl Coenzyme A Attenuates Pathological and Metabolic Cardiac Remodeling Through Selective Lipid Trafficking.
    Goldenberg JR; Carley AN; Ji R; Zhang X; Fasano M; Schulze PC; Lewandowski ED
    Circulation; 2019 Jun; 139(24):2765-2777. PubMed ID: 30909726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PPARα augments heart function and cardiac fatty acid oxidation in early experimental polymicrobial sepsis.
    Standage SW; Bennion BG; Knowles TO; Ledee DR; Portman MA; McGuire JK; Liles WC; Olson AK
    Am J Physiol Heart Circ Physiol; 2017 Feb; 312(2):H239-H249. PubMed ID: 27881386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased rates of substrate oxidation ex vivo predict the onset of heart failure and contractile dysfunction in rats with pressure overload.
    Doenst T; Pytel G; Schrepper A; Amorim P; Färber G; Shingu Y; Mohr FW; Schwarzer M
    Cardiovasc Res; 2010 Jun; 86(3):461-70. PubMed ID: 20035032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose is preferentially utilized for biomass synthesis in pressure-overloaded hearts: evidence from fatty acid-binding protein-4 and -5 knockout mice.
    Umbarawan Y; Syamsunarno MRAA; Koitabashi N; Yamaguchi A; Hanaoka H; Hishiki T; Nagahata-Naito Y; Obinata H; Sano M; Sunaga H; Matsui H; Tsushima Y; Suematsu M; Kurabayashi M; Iso T
    Cardiovasc Res; 2018 Jul; 114(8):1132-1144. PubMed ID: 29554241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary fat supply to failing hearts determines dynamic lipid signaling for nuclear receptor activation and oxidation of stored triglyceride.
    Lahey R; Wang X; Carley AN; Lewandowski ED
    Circulation; 2014 Nov; 130(20):1790-9. PubMed ID: 25266948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 1 diabetic cardiomyopathy in the Akita (Ins2WT/C96Y) mouse model is characterized by lipotoxicity and diastolic dysfunction with preserved systolic function.
    Basu R; Oudit GY; Wang X; Zhang L; Ussher JR; Lopaschuk GD; Kassiri Z
    Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2096-108. PubMed ID: 19801494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of cardiac pyruvate dehydrogenase activity in peroxisome proliferator-activated receptor-alpha transgenic mice.
    Hopkins TA; Sugden MC; Holness MJ; Kozak R; Dyck JR; Lopaschuk GD
    Am J Physiol Heart Circ Physiol; 2003 Jul; 285(1):H270-6. PubMed ID: 12663261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetic db/db mice do not develop heart failure upon pressure overload: a longitudinal in vivo PET, MRI, and MRS study on cardiac metabolic, structural, and functional adaptations.
    Abdurrachim D; Nabben M; Hoerr V; Kuhlmann MT; Bovenkamp P; Ciapaite J; Geraets IME; Coumans W; Luiken JJFP; Glatz JFC; Schäfers M; Nicolay K; Faber C; Hermann S; Prompers JJ
    Cardiovasc Res; 2017 Aug; 113(10):1148-1160. PubMed ID: 28549111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of PPAR-alpha activity in mice with cardiac-restricted expression of tumor necrosis factor: potential role of TGF-beta/Smad3.
    Sekiguchi K; Tian Q; Ishiyama M; Burchfield J; Gao F; Mann DL; Barger PM
    Am J Physiol Heart Circ Physiol; 2007 Mar; 292(3):H1443-51. PubMed ID: 17098824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Branched chain amino acids exacerbate myocardial ischemia/reperfusion vulnerability via enhancing GCN2/ATF6/PPAR-α pathway-dependent fatty acid oxidation.
    Li Y; Xiong Z; Yan W; Gao E; Cheng H; Wu G; Liu Y; Zhang L; Li C; Wang S; Fan M; Zhao H; Zhang F; Tao L
    Theranostics; 2020; 10(12):5623-5640. PubMed ID: 32373236
    [No Abstract]   [Full Text] [Related]  

  • 16. Myocardial infarction in rats causes partial impairment in insulin response associated with reduced fatty acid oxidation and mitochondrial gene expression.
    Amorim PA; Nguyen TD; Shingu Y; Schwarzer M; Mohr FW; Schrepper A; Doenst T
    J Thorac Cardiovasc Surg; 2010 Nov; 140(5):1160-7. PubMed ID: 20850803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac peroxisome proliferator-activated receptor-alpha activation causes increased fatty acid oxidation, reducing efficiency and post-ischaemic functional loss.
    Hafstad AD; Khalid AM; Hagve M; Lund T; Larsen TS; Severson DL; Clarke K; Berge RK; Aasum E
    Cardiovasc Res; 2009 Aug; 83(3):519-26. PubMed ID: 19398469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac-specific deletion of acetyl CoA carboxylase 2 prevents metabolic remodeling during pressure-overload hypertrophy.
    Kolwicz SC; Olson DP; Marney LC; Garcia-Menendez L; Synovec RE; Tian R
    Circ Res; 2012 Aug; 111(6):728-38. PubMed ID: 22730442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of actin dynamics regulated by Rho effector mDia1 attenuates pressure overload-induced cardiac hypertrophic responses and exacerbates dysfunction.
    Abe I; Terabayashi T; Hanada K; Kondo H; Teshima Y; Ishii Y; Miyoshi M; Kira S; Saito S; Tsuchimochi H; Shirai M; Yufu K; Arakane M; Daa T; Thumkeo D; Narumiya S; Takahashi N; Ishizaki T
    Cardiovasc Res; 2021 Mar; 117(4):1103-1117. PubMed ID: 32647865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tempol prevents cardiac oxidative damage and left ventricular dysfunction in the PPAR-α KO mouse.
    Guellich A; Damy T; Conti M; Claes V; Samuel JL; Pineau T; Lecarpentier Y; Coirault C
    Am J Physiol Heart Circ Physiol; 2013 Jun; 304(11):H1505-12. PubMed ID: 23542920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.